Mantle cell lymphoma (MCL) is a mature B-cell lymphoma typically characterised by the
expression of cluster of differentiation 5 (CD5) and at (11; 14) translocation resulting in …

Mantle cell lymphoma (MCL) is a rare subtype of Non-Hodgkin Lymphoma (NHL)
characterized by a heterogeneous clinical outcome. The interpatient variability is due to …

Mantle cell lymphoma (MCL) is characterized by an aggressive clinical course and
secondary resistance to currently available therapies in most cases. Therefore, despite …

Signal transduction through the constitutively activated B cell receptor (BCR) plays a key
role in the pathogenesis of B-cell tumors by promoting survival and proliferation of malignant …

Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy, which is believed to
originate from naïve B-cells in the mantle zone of lymph nodes. Recently, a more diverse …

Mantle cell lymphoma (MCL) is an incurable B-cell malignancy characterized by a high
clinical variability. Therefore, there is a critical need to define parameters that identify high …

Mantle cell lymphoma (MCL) is an aggressive disease with frequent relapse. Targeted
therapies against B‐cell receptor (BCR) molecules have demonstrated improved outcomes …

Background Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin's lymphoma (NHL)
and represents one of the most challenging lymphoma types to treat. The B-cell antigen …

Mantle cell lymphoma (MCL) is a well‐defined lymphoid neoplasm characterized by a
proliferation of mature B lymphocytes expressing CD5 that may show a spectrum of …

Mantle cell lymphoma (MCL) is a distinct subtype of malignant lymphoma which is
characterized by the chromosomal translocation t (11; 14)(q13; q32) resulting in …